Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 22% ± 7% | |
glutamatergic neuron | 4 studies | 42% ± 17% | |
GABAergic neuron | 3 studies | 44% ± 5% | |
transit amplifying cell | 3 studies | 21% ± 5% | |
astrocyte | 3 studies | 21% ± 3% | |
oligodendrocyte | 3 studies | 19% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 5233.79 | 1445 / 1445 | 100% | 50.02 | 183 / 183 |
uterus | 100% | 5115.12 | 170 / 170 | 100% | 46.91 | 459 / 459 |
breast | 100% | 3896.09 | 459 / 459 | 100% | 72.86 | 1117 / 1118 |
prostate | 100% | 3700.54 | 245 / 245 | 100% | 39.41 | 501 / 502 |
ovary | 100% | 4279.44 | 180 / 180 | 100% | 34.20 | 429 / 430 |
bladder | 100% | 4877.33 | 21 / 21 | 100% | 40.40 | 502 / 504 |
lung | 100% | 3613.79 | 576 / 578 | 100% | 48.25 | 1154 / 1155 |
brain | 100% | 3755.27 | 2629 / 2642 | 100% | 32.55 | 705 / 705 |
thymus | 100% | 3260.44 | 652 / 653 | 100% | 37.52 | 602 / 605 |
intestine | 100% | 5051.42 | 966 / 966 | 99% | 30.91 | 522 / 527 |
kidney | 100% | 3108.38 | 89 / 89 | 98% | 28.97 | 883 / 901 |
stomach | 100% | 3330.65 | 359 / 359 | 98% | 33.06 | 280 / 286 |
adrenal gland | 100% | 4119.43 | 258 / 258 | 98% | 52.56 | 225 / 230 |
skin | 100% | 3538.48 | 1806 / 1809 | 98% | 55.01 | 462 / 472 |
pancreas | 98% | 1564.96 | 320 / 328 | 99% | 39.32 | 177 / 178 |
liver | 97% | 1388.88 | 220 / 226 | 99% | 30.33 | 400 / 406 |
adipose | 100% | 4493.28 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 6640.92 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 25.20 | 29 / 29 |
muscle | 100% | 3360.52 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2319.46 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 42.59 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 39.89 | 1 / 1 |
heart | 98% | 3514.59 | 841 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 91% | 27.04 | 73 / 80 |
peripheral blood | 43% | 970.33 | 398 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030166 | Biological process | proteoglycan biosynthetic process |
GO_0006468 | Biological process | protein phosphorylation |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005515 | Molecular function | protein binding |
GO_0016773 | Molecular function | phosphotransferase activity, alcohol group as acceptor |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0016301 | Molecular function | kinase activity |
Gene name | FAM20B |
Protein name | FAM20B glycosaminoglycan xylosylkinase Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) |
Synonyms | KIAA0475 |
Description | FUNCTION: Responsible for the 2-O-phosphorylation of xylose in the glycosaminoglycan-protein linkage region of proteoglycans thereby regulating the amount of mature GAG chains. Sulfated glycosaminoglycans (GAGs), including heparan sulfate and chondroitin sulfate, are synthesized on the so-called common GAG-protein linkage region (GlcUAbeta1-3Galbeta1-3Galbeta1-4Xylbeta1-O-Ser) of core proteins, which is formed by the stepwise addition of monosaccharide residues by the respective specific glycosyltransferases. Xylose 2-O-phosphorylation may influence the catalytic activity of B3GAT3 (GlcAT-I) which completes the precursor tetrasaccharide of GAG-protein linkage regions on which the repeating disaccharide region is synthesized. . |
Accessions | O75063 X6RH03 ENST00000440702.5 ENST00000263733.5 |